Login to Your Account



Washington Roundup

Acura Shares Plummet After FDA Panel Rejects Pain Drug Acurox

By Donna Young


Monday, April 26, 2010
WASHINGTON - Shares of Acura Pharmaceuticals Inc. fell 32 percent Friday after an FDA advisory panel a day earlier refused to back approval of the firm's investigational pain drug Acurox (oxycodone HCl and niacin). (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription